Disclosure Of Interests In Other Entities [Text Block]

Mithra Pharmaceuticals S.A. - Filing #3183197

Concept As at
2021-12-31
2021-01-01 to
2021-12-31
2021-01-01 to
2021-12-31
2021-01-01 to
2021-12-31
2021-01-01 to
2021-12-31
2021-01-01 to
2021-12-31
2020-01-01 to
2020-12-31
As at
2020-12-31
2020-01-01 to
2020-12-31
2020-01-01 to
2020-12-31
2020-01-01 to
2020-12-31
2020-01-01 to
2020-12-31
As at
2019-12-31
Disclosure of interests in other entities [text block]
Disclosure of interests in subsidiaries [text block]
Disclosure of subsidiaries [text block]
Disclosure of subsidiaries [abstract]
Disclosure of subsidiaries [line items]
Current assets
99,389,000 EUR
238,475,000 EUR
Non-current assets
322,528,000 EUR
283,509,000 EUR
Current liabilities
95,793,000 EUR
70,747,000 EUR
Non-current liabilities
292,285,000 EUR
293,500,000 EUR
Revenue
22,668,000 EUR
9,030,000 EUR
Profit (loss)
116,875,000 EUR
116,875,000 EUR
92,086,000 EUR
92,086,000 EUR
Comprehensive income
17,300,000 EUR
- EUR
- EUR
134,175,000 EUR
116,875,000 EUR
92,086,000 EUR
- EUR
89,086,000 EUR
- EUR
3,000,000 EUR
Disclosure of interests in associates [text block]
Disclosure of associates [text block]
Disclosure of associates [abstract]
Disclosure of associates [line items]
Other comprehensive income
17,300,000 EUR
3,000,000 EUR
Disclosure of interests in joint arrangements [text block]
Disclosure of joint ventures [text block]
Disclosure of joint ventures [abstract]
Disclosure of joint ventures [line items]
Cash and cash equivalents
32,872,000 EUR
138,675,000 EUR
49,720,000 EUR
Other current financial liabilities
15,829,000 EUR
23,424,000 EUR
Other non-current financial liabilities
102,675,000 EUR
101,180,000 EUR
Tax expense (income)
6,895,000 EUR
18,835,000 EUR

Talk to a Data Expert

Have a question? We'll get back to you promptly.